Key facts
- This page summarizes Aron Shapiro's Form 4 filing for KIORA PHARMACEUTICALS INC (KPRX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 11 Sep 2024, 07:02.
Aron Shapiro - 10 Sep 2024 Form 4 Insider Report for KIORA PHARMACEUTICALS INC (KPRX)
- Reporting relationship
- Director
- Issuer ticker
- KPRX
- Reported as of
- 10 Sep 2024
- Net transaction value
- +$10,800
- SEC form
- 4
- Accepted by SEC
- 11 Sep 2024, 07:02:13 UTC
- Prior SEC filing
- 03 Jul 2024
- Next SEC filing
- 02 Apr 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Melissa Tosca, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Aron Shapiro filed Form 4 for KIORA PHARMACEUTICALS INC (KPRX) on 11 Sep 2024.
Change
- Previous filing in this sequence was filed on 03 Jul 2024.
- Current net transaction value: +$10,800.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
KPRX
transaction
Common Stock
Purchase
- Transaction value
- $10,800
- Shares
- +3,000
- Change %
- Price
- $3.60
- Shares after
- 3,000
- Date
- 10 Sep 2024
- Ownership
- By The Shapiro Family Irrevocable Trust
* marks a reported price that did not pass the local price check.